※主要論文に○印・corresponding author に*印を付けています。

（Ⅰ）原 著
1) 英文
1. ○Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T*: Amplification of
α-platelet-derived growth factor receptor gene lacking an exons coding for a portion of theextracellular region in a primary brain tumor of glial origin. Oncogene 7:627-633,1992,
IF=6.373, 学位論文・日本脳神経外科学会ガレーヌス賞受賞論文
2.

Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T*: Overexpression and amplificationof α-PDGF receptor gene lacking exons coding for a portion of the extracellular region in amalignant glioma. Tohoku J. Exp. Med. 168:265-269, 1992

3.

Kumabe T, Sohma Y, Yamamoto T*: Human cDNAs encoding elongation factor 1γ and theribosomal protein L19. Nucleic Acids Research 20:2598, 1992,

4.

Tominaga T*, Kayama T, Kumabe T, Sonoda Y, and Yoshimoto T: Anaplastic Ependymomas:
Clinical Features and Tumor Suppressor Gene p53 Analysis. Acta Neurochirurgica (Wien)
135:163-170, 1995

5.

Kawagishi J, Kumabe T, Yoshimoto T, and Yamamoto T*: Structure, organization andtranscription units of the human a-Platelet-Derived Growth Factor Receptor Gene. Genomics
30:224-232, 1995

6.

Shimizu H*, Kumabe T, Tominaga T, Kayama T, Hara K, Ono Y, Sato K, Arai N, Fujiwara S,
Yoshimoto T: Noninvasive evaluation of malignancy with proton magnetic resonancespectroscopy in human brain tumors. AJNR 17:737-747, 1996

7.

Hara E*, Takahashi K, Tominaga T, Kumabe T, Kayama T, Suzuki H, Fujita H, Yoshimoto T,
Shirato K, Shibahara S: Expression of heme oxygenase and inducible nitric oxide synthase mRNAin human brain tumors. Biochem Biophys Res Commun 224:153-158, 1996

8.

Nakasato N*, Kumabe T, Kanno A, Ohtomo S, Mizoi K, Yoshimoto T: Neuromagnetic evaluationof cortical auditory function in patients with temporal lobe tumors. J Neurosurg 86:610-618, 1997

9.

Takahashi K*, Satoh F, Hara E, Murakami O, Kumabe T, Tominaga T, Kayama T, Yoshimoto T,
Shibahara S: Production and secretion of adrenomedullin by cultured choroid plexus carcinoma
cells. J Neurochem 68:726-731, 1997

10. Takahashi K*, Hara E, Murakami O, Totsune K, Sone M, Satoh F, Kumabe T, Tominaga T,
Kayama T, Yoshimoto T, Shibahara S: Production and secretion of endothelin-1 by cultured
choroid plexus carcinoma cells. J Cardiovasc Pharmacol. 31 Suppl 1:S367-369, 1998
11. Kon H, Sonoda Y, Kumabe T, Yoshimoto T, Sekiya T, Nurakami Y*: Structural and functional
evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in humangliomas. Oncogene 15:257-263, 1998
12. Sonoda Y*, Kumabe T, Takahashi T, Shirane R, Yoshimoto T: Clinical usefulness of 11C-MET
PET and 201Tl SPECT for differentiation of recurrent glioma from radiation necrosis. Neurol
Med Chir (Tokyo) 38:342-348, 1998
13. Shirane R*, Shamoto H, Umezawa K, C.-C. Su, Kumabe T, Jokura H, Yoshimoto T: Surgicaltreatment of pineal region tumours through the occipital transtentorial approach: Evaluation of theeffectiveness of intra-operative micro-endoscopy combined with neuronavigation. ActaNeurochir (Wien) 141:801-809, 1999
14. Inoue T*, Shimizu H, Nakasato N, Kumabe T, Yoshimoto T: Accuracy and limitation offunctional magnetic resonance imaging for identification of the central sulcus: comparison withmagnetoencephalography in patients with brain tumors. Neuroimage 10:738-748, 1999
15. Kanamori M, Kon H, Nobukuni T, Nomura S, Sugano K, Mashiyama S, Kumabe T, Yoshimoto T,
Meuth M, Sekiya T, Murakami Y*: Microsatellite instability and the PTEN1 gene mutation in a
subset of early onset gliomas carrying germline mutation or promoter methylation of the hMLH1
gene. Oncogene 16;19(12):1564-71, 2000
16. Shimizu H, Kumabe T, Hara K, Fujiwara S, Yoshimoto T: Correlation between choline levelmeasured by proton magnetic resonance spectroscopy and Ki-67 labeling index in gliomas. AJNRAm J Neuroradiol 21:659-665, 2000
17. ○Kumabe T*, Nakasato N, Inoue T, Yoshimoto T: Primary Thumb Sensory Cortex Located at theLateral Shoulder of the Inverted Omega-shape on the Axial Images of the Central Sulcus. Neurol
Med Chir (Tokyo) 40:393-403, 2000
18. Kato H, Kato S, Kumabe T, Sonoda Y, Yoshimoto T, Kato S, Han S-Y, Kanamaru R, Ishioka C*:
Functional evaluation of p53 and PTEN gene mutations in gliomas. Clin Cancer Res
6:3937-3943, 2000
19. Yamashita Y, Kumabe T, Cho YY, Watanabe M, Yoshimoto T, Fujino T, Kang MJ, Yamamoto
TT*: Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 genelocated on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas.
Oncogene 19:5919-5925, 2000
20. Shirane R*, Kumabe T, Yoshida Y, Su CC, Jokura H, Umezawa K, Yoshimoto T: Surgicaltreatment of posterior fossa tumors via the occipital transtentorial approach: evaluation ofoperative safety and results in 14 patients with anterosuperior cerebellar tumors. J Neurosurg
94:927-935, 2001
21. Kondo T, Kumabe T*, Maruoka S, Yoshimoto T: Diagnostic value of 201Tl-single-photon
emission computerized tomography studies in cases of posterior fossa hemangioblastomas. J
Neurosurg 95:292-297, 2001
22. Nemoto K*, Ogawa Y, Matsushita H, Takeda K, Takai Y, Yamada S, Kumabe T: Intraoperative
radiation therapy (IORT) for previously untreated malignant gliomas. BMC Cancer 2:1-5, 2002
23. Kanamori M, Kumabe T*, Shimizu H, Yoshimoto T: MIB-1 labeling index, 201Tl-SPECT and
1
H-MRS of central neurocytomas. Acta Neurochir (Wien) 144:157-163, 2002
24. Karibe H*, Kumabe T, Shimizu H, Shirane R, Yoshimoto T: Assessment of neuronal tract fibers
using three-dimensional anisotropy contrast imaging in patients with infratentorial brain tumors.
International Congress Series 1232:769-775
25. Saito R, Kumabe T*, Jokura H, Shirane R, Yoshimoto T: Symptomatic Spinal Dissemination of
Malignant Astrocytoma. J Neurooncol 61: 227-235, 2003
26. Inoue T*, Akahira J, Suzuki T, Darnel AD, Kaneko C, Takahashi K, Hatori M, Shirane R,
Kumabe T, Kurokawa Y, Satomi S, Sasano H: Progesterone production and actions in the humancentral nervous system and neurogenic tumors. J Clin Endocrinol Metab 87:5325-5331, 2002

27. Hayashi T, Kumabe T*, Jokura H, Fujihara K, Shiga Y, Watanabe M, Higano S, Shirane R:
Inflammatory demyelinating disease mimicking malignant glioma. J Nucl Med 44:565-569, 2003
28. Endo H, Kumabe T*, Jokura H, Shirane R, Ariga H, Takai Y, Yoshimoto T: Leptomeningeal
dissemination of cerebellar malignant astrocytomas. J Neurooncol 63:191-199, 2003
29. Saito R*, Mizuno M, Kumabe T, Yoshimoto T, Tanuma S, Yoshida J: Apoptotic DNA
endonuclease (DNase-gamma) gene transfer induces cell death accompanying DNA
fragmentation in human glioma cells. J Neurooncol. 63:25-31, 2003
30. Kato H, Fujimura M, Kumabe T*, Ishioka C, Kanamaru R, Yoshimoto T: PTEN gene mutationand high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma. J
Clin Neurosci 11:37-41, 2004
31. Fujimura M, Kumabe T*, Jokura H, Shirane R, Yoshimoto T, Tominaga T: Intractable vomiting as
the early clinical symptom of the leptomeningeal dissemination to the fourth ventricle in patientswith malignant astrocytoma. J Neurooncol 66:209-216, 2004
32. Fujimura M, Kumabe T*, Tominaga T, Jokura H, Shirane R, Yoshimoto T: Routine clinicaladoption of magnetic resonance imaging was associated with better outcome after surgery inelderly patients with a malignant astrocytic tumour: a retrospective review. Acta Neurochir(Wien) 146:251-255, 2004
33. Saito R*, Mizuno M, Nakahara N, Tsuno T, Kumabe T, Yoshimoto T, Yoshida J: Vaccination withtumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy formalignant glioma in an experimental mouse intracranial glioma. Int J Cancer. 111:777-782, 2004
34. Saito R, Mizuno M, Hatano M, Kumabe T, Yoshimoto T, Yoshida J: Two different mechanisms ofapoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells. J
Neurooncol. 67:273-280, 2004
35. Kumabe T*, Nakasato N, Nagamatsu K, Tominaga T: Intraoperative localization of the lip
sensory area by somatosensory evoked potentials-technical note- J Clin Neurosci 12:66-70, 2005
36. Kawaguchi T, Kumabe T*, Shimizu H, Watanabe M, Tominaga T: 201Tl-SPECT and 1H-MRS
study of benign lateral ventricle tumors: differential diagnosis of subependymoma. Neurosurg
Rev 28:96-103, 2005
37. Kawaguchi T, Kato S, Otsuka K, Watanabe G, Kumabe T, Tominaga T, Yoshimoto T, Ishioka C*:
The relationship among p53 oligomer formation, structure and transcriptional activity using acomprehensive missense mutation library. Oncogene 24:6976-6981, 2005
38. Endo H, Kumabe T*, Jokura H, and Tominaga T Stereotactic radiosurgery followed by whole
ventricular irradiation for primary intracranial germinoma of the pineal region. Minim Invas
Neurosurg 48:186-190, 2005
39. Higano S*, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, Sato A, Yamada T,
Takahashi S: Malignant Astrocytic Tumors: Clinical Importance of Apparent Diffusion
Coefficient in Prediction of Grade and Prognosis. Radiology 241:839-846, 2006
40. ○Kumabe T*, Higano S, Takahashi S, Tominaga T: Ischemic complications associated withresection of opercular glioma. J Neurosurg 106:263-269, 2007

41. Sugiyama SI, Yamashita Y*, Kikuchi T, Saito R, Kumabe T, Tominaga T: Safety and efficacy of
convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor
models. J Neurooncol 82:41-47, 2007
42. Sonoda Y*, Matsumoto K, Kakuto Y, Nishino Y, Kumabe T, Tominaga T, Katakura R: Primary
CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy. Acta Neurochir(Wien) 149:1183-1189, 2007
43. Nomiya T*, Nemoto K, Kumabe T, Takai Y, Yamada S: Prognostic significance of surgery andradiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases. J
Neurosurg 106:575-581, 2007
44. Kumabe T*, Fujimura M, Jokura H, Tominaga T: Surgical treatment for choroid plexus tumors in
the fourth ventricle: brain stem infiltration hinders total extirpation. Neurosurg Rev 31:165-172,
2008
45. ○Sonoda Y, Kumabe T*, Sugiyama S, Kanamori M, Yamashita Y, Saito R, Ariga H, Takai Y,
Tominaga T: Germ cell tumors in the basal ganglia; problems of early diagnosis and treatment. J
Neurosurg Pediatrics 2:118-124, 2008
46. Kanamori M, Kumabe T*, Tominaga T: Is histological diagnosis necessary to start treatment for
germ cell tumor in the pineal region? J Clin Neurosci 15:978-987, 2008
47. Gong XY, Higano S*, Mugikura S, Umetsu A, Murata T, Kumabe T, Takahashi S: Virtually
Peeling Off the Skull and Scalp: A Simple Way of Mapping the Superficial Cerebral Veins on the
Brain Surface. Stereotact Funct Neurosurg 86:345-350, 2008
48. Kikuchi T, Saito R*, Sugiyama S, Yamashita Y, Kumabe T, Krause M, Bankiewicz K, Tominaga
T: Convection-enhanced delivery of polyethylene glycol–coated liposomal doxorubicin:
characterization and efficacy in rat intracranial glioma models. J Neurosurg 109:867-873, 2008
49. Inoue T, Yamashita Y*, Nishihara M, Sugiyama S, Sonoda Y, Kumabe T, Yokoyama M,
Tominaga T: Therapeutic efficacy of a polymeric micellar doxorubicin infused byconvection-enhanced delivery against intracranial 9L brain tumor models. Neuro Oncol
11:151-157, 2009
50. Shibahara I, Kanamori M, Kumabe T*, Endo H, Sonoda Y, Ogawa Y, Watanabe M, Tominaga T:
Hemorrhagic onset of pilocytic astrocytoma and pilomyxoid astrocytoma. Brain Tumor
Pathology 26:1-5, 2009
51. Kanamori M, Kumabe T*, Sonoda Y, Nishio Y, Watanabe M, Tominaga T: Predictive factors foroverall and progression-free survival, and dissemination in oligodendroglial tumors. J
Neurooncol 93:219-228, 2009
52. ○Kanamori M. Kumabe T*, Saito R, Yamashita Y, Sonoda Y, Ariga H, Takai Y, Tominaga T:
Optimal Treatment strategy for intracranial germ cell tumors: A single institution analysis. J
Neurosurg Pediatrics 4:506–514, 2009
53. Yamashita Y, Kumabe T*, Higano S, Watanabe M, Tominaga T: The values of minimum apparent
diffusion coefficient of medulloblastomas. Neurol Res, 31:940-946, 2009
54. Kikuchi T, Kumabe T*, Watanabe M, Tominaga T: Minimum apparent diffusion coefficient forthe differential diagnosis of ganglioglioma. Neurol Res, 31:1102-1107, 2009

55. ○Saito R, Kumabe T*, Inoue T, Takada S, Yamashita Y, Kanamori M, Sonoda Y, Tominaga T:
Magnetic resonance imaging for preoperative identification of the lenticulostriate arteries ininsular glioma surgery. Technical note. J Neurosurg 111:278-281, 2009
56. Ohtomo S, Nakasato N*, Shimizu H, Seki S, Kanno A, Kumabe T, Tominaga T: Temporo-parietal
theta activity correlates with misery perfusion in arterial occlusive disease. Clin Neurophysiol
120:1227-1234, 2009
57. Nakajima T, Kumabe T*, Kanamori M, Saito R, Tashiro M, Watanabe M, Tominaga T:
Differential diagnosis between radiation necrosis and glioma progression using sequential proton
magnetic resonance spectroscopy and methionine positron emission tomography. Neurol Med
Chir (Tokyo) 49:394-401, 2009
58. ○Sonoda Y*, Kumabe T, Nakamura T, Saito R, Kanamor M, Yamashita Y, Tominaga T: Analysisof the IDH1 codon 132 mutations in Japanese glioma patients. Cancer Sci 100:1996-1998, 2009
59. Sonoda Y*, Kumabe T, Watanabe M, Nakazato Y, Inoue T, Kanamori M, Tominaga T: Long-term
survivors of glioblastoma: Clinical features and molecular analysis. Acta Neurochir (Wien) 151:
1349-1358, 2009
60. Sonoda Y*, Yokosawa M, Saito R, Kanamori M, Yamashita Y, Kumabe T, Watanabe M,
Tominaga T: O (6)-Methylguanine DNA methyltransferase determined by promoter
hypermethylation and immunohistochemical expression is correlated with progression-freesurvival in patients with glioblastoma. Int J Clin Oncol 15:352-358, 2010
61. ○Shibahara I, Kumabe T*, Kanamori M, Saito R, Sonoda Y, Watanabe M, Iwata R, Takanami K,
Takai Y, Tominaga T: Imaging of hypoxic tissues in glioblastoma by PET with [18F]FRP-170, a
new 18F-labeled 2-nitroimidazole analog. J Neurosurg 113:358-368, 2010
62. Saito R, Kumabe T*, Kanamori M, Sonoda Y, Tominaga T: T Dissemination limits the survival ofpatients with anaplastic ependymoma after extensive surgical resection, meticulous follow up,
and intensive treatment for recurrence. Neurosurg Rev 33:185-191, 2010
63. Sato A, Sakurada K, Kumabe T, Sasajima T, Beppu T, Asano K, Ohkuma H, Ogawa A, Mizoi K,
Tominaga T, Kitanaka C*, Kayama T; Tohoku Brain Tumor Study Group: Association of stem
cell marker CD133 expression with dissemination of glioblastomas. Neurosurg Rev 33:175-183,
2010
64. Saito R, Kumabe T*, Kanamori M, Sonoda Y, Tominaga T: Insulo-opercular gliomas: four
different progression patterns and implications for surgical indications. Neurol Med Chir (Tokyo)
50:286-290, 2010
65. Sato I*, Higuchi A, Yanagisawa T, Mukasa A, Ida K, Sawamura Y, Sugiyama K, Saito N, Kumabe
T, Terasaki M, Nishikawa R, Ishida Y, Kamibeppu K: Development of the Japanese version of thePediatric Quality of Life Inventory Brain Tumor Module. Health Qual Life Outcomes 8:38, 2010
66. Yokosawa M, Sonoda Y*, Sugiyama S, Saito R, Yamashita Y, Nishihara M, Satoh T, Kumabe T,
Yokoyama M, Tominaga T: Convection-enhanced delivery of a synthetic retinoid am80, loaded
into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma
xenografts. Tohoku J Exp Med 221:257-264, 2010
67. Yamashita Y*, Kasugai I, Sato M, Tanuma N, Sato I, Nomura M, Yamashita K, Sonoda Y,
Kumabe T, Tominaga T, Katakura R, Shima H: CDC25A mRNA levels significantly correlatewith Ki-67 expression in human glioma samples. J Neurooncol 100:43-49, 2010

68. Kawaguchi T, Kumabe T*, Kanamori M, Nakamura T, Saito R, Yamashita Y, Sonoda Y, Watanabe
M, Tominaga T: Early detection of venous thromboembolism in patients with neuroepithelial
tumor: efficacy of screening with serum D-dimer measurements and Doppler ultrasonography. J
Neurooncol 101:495-504, 2011
69. Inoue T, Kumabe T*, Kanamori M, Sonoda Y, Watanabe M, Tominaga T: Prognostic factors forpatients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases. Neurosurg Rev
34:197-208, 2011
70. ○Kawaguchi T, Kumabe T*, Kanamori M, Saito R, Yamashita Y, Sonoda Y, Watanabe M,
Tominaga T: Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin
in response to chemotherapy can distinguish a subgroup with better prognosis among highly
malignant intracranial non-germinomatous germ cell tumors. J Neurooncol 104:779-787, 2011
71. Shibahara I, Sonoda Y*, Kanamori M, Saito R, Kumabe T, Tominaga T: New insights into glioma
classification based on isocitrate dehydrogenase 1 and 2 gene status. Brain Tumor Pathol 28:203–
208, 2011
72. Nakamura T, Saito R*, Sugiyama SI, Sonoda Y, Kumabe T, Tominaga T: Local
convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier
and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model. Cancer
Lett 310:77-83, 201173. Saito R, Kumabe T*, Sonoda Y, Kanamori M, Yamashita Y, Watanabe M, Tominaga T:
Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single
institute experience and differences in efficacy for subgroups of medulloblastoma. Child’s Nerv
Syst 27:1399-1406, 201174. Saito R, Kumabe T*, Kanamori M, Yamashita Y, Sonoda Y, Higano S, Takahashi S, Tominaga T:
Preoperative evaluation of the deep cerebral veins using 3-Tesla magnetic resonance imaging.
Minim Invasive Neurosurg 54:105-109
75. ○Saito R*, Sonoda Y, Kumabe T, Nagamatsu K, Watanabe M, Tominaga T: Regression ofrecurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustinehydrochloride. J Neurosurg Pediatr. 7:522-526, 201176. Shibahara I, Sonoda Y*, Kanamori M, Saito R, Yamashita Y, Kumabe T, Watanabe M, Suzuki H,
Kato S, Ishioka C, Tominaga T: IDH1/2 gene status defines the prognosis and molecular profiles
in patients with grade III gliomas. Int J Clin Oncol. 2011 Oct 6. [Epub ahead of print]
77. Sato I*, Higuchi A, Yanagisawa T, Mukasa A, Ida K, Sawamura Y, Sugiyama K, Saito N, Kumabe
T, Terasaki M, Nishikawa R, Ishida Y, Kamibeppu K: Factors influencing self- andparent-reporting health-related quality of life in children with brain tumors. Qual Life Res. 2012
Mar 3. [Epub ahead of print]
78. Aizawa-Kohama M, Kumabe T*, Saito R, Kanamori M, Yamashita Y, Sonoda Y, Watanabe M,
Tominaga T: Clinicopathological analyses of nine consecutive central nervous system primitive
neuroectodermal tumors in a single institute. Brain Tumor Pathol 2012 March 21. [Epub ahead ofprint]
79. Ito A, Kumabe T*, Saito R, Sonoda Y, Watanabe M, Nakazato Y, Tominaga T: Malignant
pediatric brain tumor of primitive small round cell proliferation with bland-looking mesenchymal
spindle cell elements-Case report-. Brain Tumor Pathol 2012 Jun 10. [Epub ahead of print]

80. Sugiyama SI, Saito R*, Nakamura T, Yamashita Y, Yokosawa M, Sonoda Y, Kumabe T, Watanabe
M, Tominaga T: Safety and feasibility of convection-enhanced delivery of nimustinehydrochloride co-infused with free gadolinium for real-time monitoring in the primate brain.
Neurol Res 34:581-587, 2012
81. Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stütz AM, Korshunov A,
Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, Dubuc
A, Yao Y, Ramaswamy V, Luu B, Rolider A, Cavalli FM, Wang X, Remke M, Wu X, Chiu RY,
Chu A, Chuah E, Corbett RD, Hoad GR, Jackman SD, Li Y, Lo A, Mungall KL, Nip KM, Qian
JQ, Raymond AG, Thiessen NT, Varhol RJ, Birol I, Moore RA, Mungall AJ, Holt R, Kawauchi D,
Roussel MF, Kool M, Jones DT, Witt H, Fernandez-L A, Kenney AM, Wechsler-Reya RJ, Dirks P,
Aviv T, Grajkowska WA, Perek-Polnik M, Haberler CC, Delattre O, Reynaud SS, Doz FF,
Pernet-Fattet SS, Cho BK, Kim SK, Wang KC, Scheurlen W, Eberhart CG, Fèvre-Montange M,
Jouvet A, Pollack IF, Fan X, Muraszko KM, Gillespie GY, Di Rocco C, Massimi L, Michiels EM,
Kloosterhof NK, French PJ, Kros JM, Olson JM, Ellenbogen RG, Zitterbart K, Kren L, Thompson
RC, Cooper MK, Lach B, McLendon RE, Bigner DD, Fontebasso A, Albrecht S, Jabado N,
Lindsey JC, Bailey S, Gupta N, Weiss WA, Bognár L, Klekner A, Van Meter TE, Kumabe T,
Tominaga T, Elbabaa SK, Leonard JR, Rubin JB, Liau LM, Van Meir EG, Fouladi M, Nakamura
H, Cinalli G, Garami M, Hauser P, Saad AG, Iolascon A, Jung S, Carlotti CG, Vibhakar R, Ra YS,
Robinson S, Zollo M, Faria CC, Chan JA, Levy ML, Sorensen PH, Meyerson M, Pomeroy SL,
Cho YJ, Bader GD, Tabori U, Hawkins CE, Bouffet E, Scherer SW, Rutka JT, Malkin D, Clifford
SC, Jones SJ, Korbel JO, Pfister SM, Marra MA, Taylor MD: Subgroup-specific structuralvariation across 1,000 medulloblastoma genomes. Nature 488:49-56, 2012,
82. Kanoke A, Kanamori M, Kumabe T, Saito R, Watanabe M, Tominaga T: Metachronous,
multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component andoligodendroglioma through distinct genetic aberrations. J Neurosurg. 2013 Apr;118(4):854-8.
doi: 10.3171/2012.9.JNS112353. Epub 2012 Oct 19.
83. Shibui S, Narita Y, Mizusawa J, Beppu T, Ogasawara K, Sawamura Y, Kobayashi H, Nishikawa
R, Mishima K, Muragaki Y, Maruyama T, Kuratsu J, Nakamura H, Kochi M, Minamida Y,
Yamaki T, Kumabe T, Tominaga T, Kayama T, Sakurada K, Nagane M, Kobayashi K, Nakamura
H, Ito T, Yazaki T, Sasaki H, Tanaka K, Takahashi H, Asai A, Todo T, Wakabayashi T, Takahashi
J, Takano S, Fujimaki T, Sumi M, Miyakita Y, Nakazato Y, Sato A, Fukuda H, Nomura K:
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU)
versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma andglioblastoma (JCOG0305). Cancer Chemother Pharmacol. 2013 Feb;71(2):511-21. doi:
10.1007/s00280-012-2041-5. Epub 2012 Dec 11.
84. Saito R, Kumabe T, Kanamori M, Sonoda Y, Mugikura S, Takahashi S, Tomonaga T: Medial
posterior choroidal artery territory infarction associated with tumor removal in thepineal/tectum/thalamus region through the occipital transtentorial approach. Clin Neurol
Neurosurg. 2012 Dec 19. doi:pii: S0303-8467(12)00598-7. 10.1016/j.clineuro.2012.11.020.
[Epub ahead of print]
85. Saito R, Kumabe T, Sonoda Y, Kanamori M, Mugikura S, Takahashi S, Tomonaga T: Infarctionof the lateral posterior choroidal artery territory after manipulation of the choroid plexus at theatrium: causal association with subependymal artery injury. J Neurosurg. 2013 Mar 29. [Epubahead of print]
86. Mano Y, Kumabe T, Shibahara I, Saito R, Sonoda Y, Watanabe M, Tominaga T: Dynamicchanges in magnetic resonance imaging appearance of dysembryoplastic neuroepithelial tumor
with or without malignant transformation. J Neurosurg Pediatr . 2013 May;11(5):518-25. doi:10.3171/2013.1.PEDS11449. Epub 2013 Feb 22.
87. Miyatake SI, Furuse M, Kawabata S, Maruyama T, Kumabe T, Kuroiwa T, Ono K: Bevacizumab
treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent
malignant gliomas. Report of 2 cases. Neuro Oncol. 2013 Mar 3. [Epub ahead of print]
88. Kaneko MK, Morita S, Tsujimoto Y, Yanagiya R, Nasu K, Sasaki H, Hozumi Y, Goto K,
Natsume A, Watanabe M, Kumabe T, Takano S, Kato Y: Establishment of novel monoclonal
antibodies KMab-1 and MMab-1 specific for IDH2 mutations. Biochem Biophys Res Commun.
2013 Mar 1;432(1):40-5. doi: 10.1016/j.bbrc.2013.01.088. Epub 2013 Jan 31.
89. Fauchon F, Hasselblatt M, Jouvet A, Champier J, Popovic M, Kirollos R, Santarius T, Amemiya
S, Kumabe T, Frappaz D, Lonjon M, Fèvre Montange M, Vasiljevic A: Role of surgery,radiotherapy and chemotherapy in papillary tumors of the pineal region: a multicenter study. J
Neurooncol. 2013 Apr;112(2):223-31. doi: 10.1007/s11060-013-1050-5. Epub 2013 Jan 12.
90. Sugiyama SI, Saito R, Funamoto K, Nakayama T, Sonoda Y, Yamashita Y, Inoue T, Kumabe T,
Hayase T, Tominaga T: Computational simulation of convection enhanced drug delivery in the
non-human primate brainstem: a simple model predicting the drug distribution. Neurol Res. 2013
May 7. [Epub ahead of print]
91. Shibahara I, Sonoda Y, Saito R, Kanamori M, Yamashita Y, Kumabe T, Watanabe M, Suzuki H,
Watanabe T, Ishioka C, Tominaga T: The expression status of CD133 is associated with thepattern and timing of primary glioblastoma recurrence. Neuro Oncol. 2013 May 7. [Epub aheadof print]
92. Chonan M, Kanamori M, Kumabe T, Saito R, Watanabe M, Tominaga T: Pilomyxoid
astrocytoma of the cerebellum with Williams syndrome: a case report. Childs Nerv Syst. 2013
Apr 20. [Epub ahead of print]
93. Miyatake S, Furuse M, Kawabata S, Maruyama T, Kumabe T, Kuroiwa T, Ono K: Bevacizumab
treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent
malignant gliomas. Report of 2 cases. Neuro Oncol. 2013 Jun;15(6):650-5. doi:
10.1093/neuonc/not020. Epub 2013 Mar 3.
2) 和文
1. 隈部俊宏*、嘉山孝正、吉本高志、溝井和夫：Malignant Astrocytoma 初期治療後 Complete
Response 症例の検討. No Shinkei Geka 22:545-551, 1994
2.

刈部 博*、隈部俊宏、石橋安彦、酒井邦雄、椎名巌造：脳神経外科領域における MRSA
保菌者に対する補剤の効果 No Shinkei Geka 25:893-897, 19973.

隈部俊宏*、中里信和、井上 敬、岩崎真樹、大友 智、近藤健男、吉本高志：中心溝と機能局在同定における逆Ω型構造認識の重要性. 機能的脳神経外科 38:6-7, 19994.

隈部俊宏*、中里信和、近藤健男、井上 敬、岩崎真樹、吉本高志：Diffusion MRI,
neuronavigation system, 皮質および皮質下電気刺激併用による錐体路温存手術 Video
Journal of Japan Neurosurgery. Vol 8, No 3, 2000

5.

隈部俊宏*、中里信和、鈴木匡子、永松謙一、岩崎真樹、井上 敬、吉本高志：運動領野周辺神経膠腫に対する手術—術前解剖学的及び機能的マッピングの融合とニューロ
ナビゲーションシステム及び術中マッピング併用による運動機能温存手術— 脳神経外科ジャーナル（脳外誌）10:56-64, 2001
6.

隈部俊宏*、中里信和、岩崎真樹、永松謙一、清水宏明、吉本高志：中心前回に存在する神経膠腫の手術. 脳神経外科ジャーナル（脳外誌） 11:271-277, 20027.

隈部俊宏*、日下康子、城倉英史、池田秀敏、白根礼造、吉本高志：化学療法単独で治療した頭蓋内胚腫の再発. No Shinkei Geka 30:935-942, 20028.

中里信和*、菅野彰剛、社本 博、隈部俊宏、冨永悌二：誘発電位・誘発磁界による脳機能マッピング. No Shinkei Geka 30:1030-1037, 20039.

林 俊哲*、隈部俊宏、日下康子、白根礼造、冨永悌二：髄芽腫に対する治療と転帰. 小児の脳神経 29:229-235, 2004

10. 隈部俊宏*、高井良尋、嘉山孝正、冨永悌二：悪性星細胞腫の治療成績の変遷と手術療法の意義. 脳神経外科ジャーナル（脳外誌）14:132-137, 2005
11. 隈部俊宏*、冨永悌二：血管温存に留意した神経膠腫摘出術. No Shinkei Geka 33:19-27,
2005, IF=0.131, CI=0
12. 野下展生、隈部俊宏*、嘉山孝正、冨永悌二：脈絡叢乳頭腫/乳頭癌 7 例の検討. No Shinkei
Geka 34：73-81，2006
13. 齋藤竜太、隈部俊宏*、冨永悌二：発症時に脳卒中と診断された神経膠腫症例. 脳神経外科ジャーナル（脳外誌）15:121-127, 2006
14. 新妻邦泰、隈部俊宏*、清水宏明、日向野修一、高橋昭喜、冨永悌二：Fiber Tracking 法を用いた白質線維描出の問題点. 脳神経外科ジャーナル（脳外誌）16:504-509, 2007
15. 隈部俊宏*、日向野修一、高橋昭喜、冨永悌二：弁蓋部神経膠腫摘出における虚血合併症. 臨床放射線 52:767-777, 2007
16. 中川敦寛*、隈部俊宏、金森政之、斎藤竜太、平野孝幸、高山和喜、冨永悌二：パルスレーザージェットメス：神経膠腫手術への臨床応用. No Shinkei Geka 36:1005-1010, 2008
17. 永松謙一、隈部俊宏*、鈴木匡子、中里信和、佐藤清貴、飯塚 統、金森政之、園田順
彦、冨永悌二：覚醒下手術時の言語野マッピングにおける陰性運動反応の特徴と意義.
No Shinkei Geka 36:693-700, 2008
18. 川口奉洋、隈部俊宏*、金森政之、山下洋二、園田順彦、渡辺みか、冨永悌二：悪性神経膠腫における静脈血栓塞栓症 脳神経外科ジャーナル（脳外誌）18:294-299, 200919. 隈部俊宏*、金森政之、永松謙一、斉藤竜太、園田順彦、渡辺みか、冨永悌二：Diffuse
astrocytoma に対する手術療法. 脳神経外科ジャーナル（脳外誌）18:428-434, 2009
20. 赤松洋祐、隈部俊宏*、金森政之、永松謙一、斉藤竜太 園田順彦 佐藤清貴 冨永悌
二：頭部固定を必要としない術中ニューロナビゲーションシステム. No Shinkei Geka
37:1193-1199, 2009
21. 遠藤佳子、鈴木匡子*、平山和美、藤井俊勝、隈部俊宏、森悦朗：文字処理過程における運動覚の役割ー左頭頂葉損傷による失読失書例の検討. Brain Nerve. 62:991-996, 2010

22. 金森政之、隈部俊宏*、斎藤竜太、山下洋二、園田順彦、冨永悌二：ICE（イホマイド・
シスプラチン・エトポシド）療法の安全性と治療効果：単一施設の 108 連続症例の検討から. No Shinkei Geka 38:997-1005, 2010
23. 隈部俊宏*、岩崎真樹、永松謙一、関 慎太郎、斉藤竜太、金森政之、山下洋二、園田
順彦、佐藤清貴、中里信和、冨永悌二：覚醒下手術がもたらしたもの. 特集：悪性グリ
オーマ治療の進歩. 脳神経外科ジャーナル（脳外誌）19:907-915, 2010
24. 園田順彦*、隈部俊宏、斉藤竜太、金森政之、山下洋二、麦倉俊二、冨永悌二：頭蓋内胚細胞性腫瘍の集学的治療の現状と長期成績. Jpn J Neurosurg (Tokyo) 20:372-378, 2011
25. 園田順彦*、隈部俊宏、斉藤竜太、金森政之、山下洋二、冨永悌二：小児神経膠腫の治療コンセンサス. Jpn J Neurosurg (Tokyo) 21:224-235, 2012
26. 隈部俊宏、冨永悌二：神経膠腫摘出における覚醒下脳機能マッピングの変遷. 脳外速報
22:429-440, 201227. 隈部俊宏：こどもの脳腫瘍. やさしい医学 36. Brain 107:6-7, 201228. 隈部俊宏、冨永悌二：小児期にみられる脳腫瘍. BRAIN Vol.2 No.9, 811-817, 2012
29. 園田順彦、隈部俊宏、斉藤竜太、金森政之、山下洋二、冨永悌二：小児神経膠腫の治療
コンセンサス. Jpn J Neurosurg (Tokyo) 21:224-235, 201230. 成澤あゆみ、隈部俊宏、斉藤竜太、園田順彦、渡辺みか、冨永悌二：第３脳室 chordoid
glioma の 1 例. 教訓的症例に学ぶシリーズ. No Shinkei Geka, 40:805-811, 2012